GL1X · GenesisL1 explorer

Research workbench

Crystal structure of E. COLI phosphoenolpyruvate carboxykinase mutant LYS254SER

Analyse Crystal structure of E. COLI phosphoenolpyruvate carboxykinase mutant LYS254SER in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6V2N
Type
protein
Length
518 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphoenolpyruvate carboxykinase (ATP)
EC
4.1.1.49
UniProt
A0A400L9R1
Ligands
CA
Pockets
2 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphoenolpyruvate carboxykinase (ATP) (EC 4.1.1.49)protein51830% helix, 25% strandA0A400L9R1

Ligands and binding sites

  • CA · Calcium ion · metal · chains A
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15870.660.7762CA, ACT
2880.370.7620empty

Compared structures

  • 6V2N · Crystal structure of E. coli phosphoenolpyruvate carboxykinase mutant Lys254Ser · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.